baber/WOPTO huggingface dataset:
Patent MX-156578-A (MX)
Inventor: KLEPA PETER P
IPC: F04B13/02
Filed: 1982-09-21
Abstract: Apparatus (10) for automatically dispensing a liquid treatment chemical (12) from a replaceable supply bottle (14) into an intermittently flowing liquid stream (22) such as a recirculating water supply for a refrigeration system. The apparatus has a feeder chamber (16) into which the liquid stream (22) flows which is periodically emptied by a siphon tube (18) when the liquid reaches a level sufficient to establish a siphon effect in the siphon tube (18). The rising level of liquid (22) in the chamber (16) also actuates, by means of a float (24), the valve portion (31) of a closure assembly (30) on the inverted top of the supply bottle (14). The valve portion (31) is fed by a capillary tube (50) and dispenses a predetermined, very small quantity of chemical each time it is actuated. The valve portion (31) is prevented from becoming clogged by chemical crystals during inactive periods by being mounted so that its surface will be flushed each cycle by the water (22) which rises in the feeder chamber (16).
Patent NZ-194352-A (NZ)
Title: Centrifugal water purifier
Inventor: LAFONTAINE P
IPC: C02F9/00
Filed: 1980-07-15
Abstract: The portable water purifier comprises a rotary filtering vessel which is surrounded by a compartment designed to collect the water filtered through the lateral wall of the filtering vessel, this vessel being rotatably mounted on its axis of revolution. It also comprises a rotary drive member whose output shaft is made fastened to the rotary filtering vessel and a flow pipe for the filtered water which communicates with the outside and with the bottom of the compartment for collecting the filtered water, and a container for the water to be filtered including means enabling the water to be passed into the rotary vessel.
Patent NZ-207673-A (NZ)
Title: Macrolides and pharmaceutical and veterinary compositions
Inventor: OMURA SATOSHI
IPC: A61K35/74
Filed: 1984-03-28
Abstract: Macrolides which can be prepared by the aerobic cultivation of Streptomyces ambofaciens ATCC 15154 are useful antibiotics. The macrolides are designated PTL-448-A, B, C and D, or have the formulawherein R' is hydrogen or acetyl, and R' is hydrogen or mycarosyl; or a pharmaceutically-acceptable salt thereof.
Patent NZ-220811-A (NZ)
Title: Assembly of container and dispenser with non-reusable connector
Inventor: SHADWELL DAVID WILLIAM
IPC: B65D55/02
Filed: 1987-06-23
Abstract: A connection device for two components, for example a container and a dispenser, provided with a member moveable between two positions. In the first position the member permits engagement of the two components. The member moves between the first and second position upon either connection or disconnection of the components and can not be readily moved back to the first position with the member. In the second position the components can not be re-engaged.
Patent NZ-222715-A (NZ)
Title: Steel shaft with pointed and forked inserts wedged in ends
Inventor: HEILIGER MARTHA-CATHARINA
IPC: E21D17/00
Filed: 1987-11-27
Abstract: A steel cap for steel sets in mining support structures is made of a hollow sectional profile having a certain length. A tip is arranged as an insert at one end of the sectional profile. A fork is arranged as an insert at the other end of the sectional profile. Each insert is formed as a plug-in connection. The plug-in connection is provided with a hold free of play in a correct position. For this purpose each insert has at its end facing the sectional profile, a plug with a cross-section corresponding to that of the sectional profile, and at least one surface inclined relative to the longitudinal axis of the steel cap. At least one movable wedge element is arranged for cooperation with each inclined surface. A wedge drive permits driving the wedge element or elements into or out of a locking position relative to the respective inclined surface.
Patent NZ-225627-A (NZ)
Title: Icemaking apparatus including at least one rotatable refrigeration disc
Inventor: LYON DOUGLAS JAMES
IPC: F25C1/142
Filed: 1988-07-29
Abstract: Apparatus for continuous production of flake ice comprises one or more refrigerated discs (20) mounted on a hollow shaft (18, 21, 71). Each disc (20) rotates in the vertical plane and includes a plurality of narrow internal channels (30) which extend substantially over all of the operative portion of the disc (20) and are of substantially equal length. The disc(s) (20) forms(s) the evaporator of a refrigeration circuit, and an evaporative refrigerant is circulated to the channels (30) in each disc (20) via the hollow shaft (18, 21, 71). During each cycle, water is applied to both external flat surfaces of each disc (20) at a first angular location and the film of water which adheres thereto freezes as the disc (20) rotates. The ice sheet so formed is removed from both sides of the disc (20) at a second angular location by scraper blades (40, 75).
Patent NZ-228376-A (NZ)
Title: Method of delivering bioactive agents to mucosally associated lymphoreticular tissue and compositions therefor
Inventor: TICE THOMAS R
IPC: A61K9/56
Filed: 1989-03-17
Abstract: A method, and compositions for use therein capable, of delivering a bioactive agent to an animal entailing the steps of encapsulating effective amounts of the agent in a biocompatible excipient to form microcapsules having a size less than approximately ten micrometers and administering effective amounts of the microcapsules to the animal. A pulsatile response is obtained, as well as mucosal and systemic immunity.
Patent NZ-230584-A (NZ)
Title: Ultrasonic tyre inspection
Inventor: CUSHMAN CHARLES RICHARD
IPC: G01N29/27
Filed: 1989-09-06
Abstract: An apparatus for inspecting a tire for structural defects as the tire is rotated on a stand comprises a movable transducer transmitter for directing a plurality of successive collimated bursts of ultrasonic energy against the tire surface, said bursts passing through the tire and forming inspection areas having the same diameter and overlapping each other as the tire is rotated during an inspection cycle. A movable receiver transducer located on the other side of the tire from the transmitter is constantly positioned to receive the collimated ultrasonic energy that passes through each inspection area. Coordination control elements are provided for moving the transmitter transducer and the receiver transducer from one side of the tire to the other generally parallel to its axis of rotation while successive ultrasonic bursts are directed through the tire as it rotates during each inspection test and while maintaining substantially the same distance between the transducers for each burst. The strength of the energy received by the receiver transducer is evaluated for each burst when the evaluation indicates that a defect is present, a visual indicator is triggered to identify the location of the structural defect in the tire being inspected.
Patent NZ-237064-A (NZ)
Title: Substituted pyridinemethanol derivatives and plant fungicides
Inventor: ZIERKE THOMAS
IPC: C07D213/89
Filed: 1991-02-11
Abstract: Compounds of the formula 1   <IMAGE> 1  where R is unsubstituted or substituted cycloalkyl or cycloalkenyl, X, Y and Z are hydrogen, halogen, alkyl, alkoxy, alkoximino, haloalkyl, cyano, nitro or unsubstituted or substituted phenyl or phenoxy, W is -CH2- or -CH2CH2- and n is 0 or 1, and the plant-tolerated acid-addition salts thereof, and fungicides containing these compounds are described.
Patent NZ-239293-A (NZ)
Title: Films comprising porous filler having a particle size greater than the film thickness in an amount to reduce the ratio of co 2 /o 2 permeability; packaging of fruits and vegetables
Inventor: CHRISTIE GREGOR BRUCE YEO
IPC: C08L23/00
Filed: 1991-08-07
Abstract: A controlled permeability film including a film forming polymer and optionally including a dispersing polymer; and an inert porous filler optionally having a surface modifying agent coated thereon, the inert porous filler being present in an amount effective to reduce the ratio of the carbon dioxide permeability to the oxigen permeability of the film, and wherein the filler has a particle size greater than the intrinsic film thickness of the film forming polymer. A composite packaging article and a packaged produce product are also disclosed.
Patent NZ-244535-A (NZ)
Title: Nucleosides linked via oxygen to a fatty acid; anti viral compositions
Inventor: DALEN ARE
IPC: A61P31/18
Filed: 1992-09-29
Abstract: Fatty acid esters (I) of nucleosides or nucleoside analogues are new, where the fatty acid is a monounsatd. 18 to 20C fatty acid esterified with the 5'-OH gp. of nucleosides or with an OH gp. on the noncyclic chain of nucleoside analogues. (I) have higher activity than the parent nucleosides or analogues and have relatively low toxicity. Pref., (I) are esters of acyclovir, Ara T, Ara A or AZT with oleic acid, elaidic acid or cis- or trans-eicosenic acid.
Patent NZ-264892-A (NZ)
Title: Use of melatonin derivatives for treating sleep disorders
Inventor: FLAUGH MICHAEL EDWARD
IPC: C07D209/14
Filed: 1994-11-10
Abstract: The present invention provides a method of treating sleep disorders using various melatonin analogs. The invention further provides pharmaceutical formulations suitable for use in such method.
Patent NZ-295894-A (NZ)
Title: Apparatus for electrostatic charging of resinous powder particles in fluidised bed
Inventor: WILLIAMS BARBARA E
IPC: B05B5/08
Filed: 1995-10-03
Abstract: An apparatus for improving the electrostatic charge developed on a resin powder composition for electrostatic coating of solid objects and the method of application thereof. The apparatus comprises a device for charging the powder by electrical induction/conduction such that the powder particles have a resistivity of from about 109 to about 1013 ohm.meters at 20 percent relative humidity and spraying the charged powder onto an grounded solid object to which it adheres prior to the thermal fusing to produce a permanent finish.
Patent NZ-323456-A (NZ)
Title: Pharmaceutical composition of an estrogen agonist/antagonist and a prostaglandin or a prostaglandin agonist/antagonist; useful for combination therapy for osteoporosis
Inventor: KE HUA ZHU
IPC: A61K38/29
Filed: 1996-12-23
Abstract: The pharmaceutical composition comprises a therapeutically effective amount of a first compound, the first compound being an estrogen agonist/antagonist; and a therapeutically effective amount of a second compound, the second compound being a prostaglandin or a prostaglandin agonist/antagonist. These compositions are useful for the treatment of low bone mass conditions such as osteoporosis and post-menopausal bone loss.
Patent NZ-324921-A (NZ)
Title: Cathepsin K crystal structure and methods of identifying inhibitors of this protease
Inventor: ABDEL-MEDQUID SHERIN SALAHELDI
IPC: A61P43/00
Filed: 1996-10-30
Abstract: The specification describes the crystalline structure of cathepsin K. Also disclosed are methods of identifying inhibitors of this protease and methods of inhibiting cathepsin K using inhibitors with certain structural, physical and spatial characteristics.
Patent NZ-332272-A (NZ)
Title: Preparing frozen par-fried potato strips having a crisp surface and moist interior when oven finished
Inventor: WALSH BELLE CROMWELL
IPC: A23L19/18
Filed: 1997-04-16
Abstract: A process, for preparing frozen, par-fried potato strips for subsequent finishing in an oven prior to consumption, comprises (a) parfrying potato strips in oil at a temperature of from 270 °F (132 °C) to 385 °F (196 °C) for a time sufficient to reduce the moisture content of the par-fries to from 30 % to 50 %, (b) hydrating the surface of said par-fries by application of water or an aqueous solution or dispersion until the weight thereof is increased by from 1 % to 12 %, and (c) freezing said hydrated par-fries.  The frozen, hydrated par-fries comprise from 35 % to 55 % moisture.  The par-fries from step (a) may be frozen prior to hydration of the surface.
Patent NZ-333323-A (NZ)
Title: A synthetic plant core promoter
Inventor: BRUCE WESLEY B
IPC: C12N15/82
Filed: 1997-06-10
Abstract: A synthetic DNA plant promoter sequence comprising a TATA motif; a transcription start site and a region between the TATA motif and the start site that is at least 64% GC-rich is claimed. Also claimed is an expression cassette comprising a synthetic promoter comprising a TATA motif; a transcription start site and a region between the TATA motif and the start site that is at least 64% GC-rich; a structural gene operatively linked to the promoter and a transcription end site polyadenylation signal. A vector comprising the promoter described above and a transgenic plant transformed by the vector are also claimed.
Patent NZ-337179-A (NZ)
Title: Process for the preparation of substituted thiazolidinedione specifically benzylidene thiazolidine-2,4-dione is selectively reduced to benzyl thiazolidine-2,4-dione by use of a complex hydride reducing agent
Inventor: GILES ROBERT GORDON
IPC: C07D417/10
Filed: 1998-02-13
Abstract: A process for preparing a compound of formula I, or a tautomeric form, a pharmaceutically acceptable salt, or a pharmaceutically acceptable solvate thereof, wherein: J represents O or S; T represents a substituted or unsubstituted aryl group and T1 is O or S. The process comprises reducing a compound of formula II, or a tautomeric form, salt, or solvate thereof, wherein T and T1 are as defined in relation to formula I, with a complex hydride reducing agent or a source of a complex hydride reducing agent, such as a borohydride or an aluminium hydride reducing agent.
Patent NZ-337488-A (NZ)
Title: Managing displayed message priorities in an EPL system
Inventor: GOODWIN JOHN COKER
IPC: G06Q20/20
Filed: 1999-08-30
Abstract: Records are provided for an EPL (electronic price label) 18 in data file 28, 32.  Each record has a different message to be displayed by the EPL 18 with respective priority, start and end time. The data file is read to identify all records for EPL 18.  Priorities are determined and displayed at start times in accordance with these priorities.
Patent NZ-337522-A (NZ)
Title: Chimeric flavivirus incorporating yellow fever virus modified such that a prM-E protein of a second flavivirus is expressed, and vaccines for flavivruses
Inventor: CHAMBERS THOMAS J
IPC: C07K14/18
Filed: 1998-03-02
Abstract: A chimeric live, infectious, attenuated virus, containing a yellow fever virus, in which the nucleotide sequence for a prM-E protein is either deleted, truncated, or mutated, so that functional prM-E protein is not expressed, and integrated into the genome of the yellow fever virus, a nucleotide sequence encoding a prM-E protein of a second, different flavivirus, so that the prM-E protein of the second flavivirus is expressed.
Patent NZ-502078-A (NZ)
Title: Improved method for preparing low-concentration polyaluminosilicate microgels
Inventor: MOFFETT ROBERT HARVEY
IPC: C01B33/26
Filed: 1997-06-04
Abstract: The specification describes a method for preparing low-concentration polyaluminosilicate microgels from a first stream containing a water soluble silicate and a second stream containing a strong acid having a pKa of less than 6. The silicate and acid are mixed at a rate to produce a Reynolds number of at least 4000, the mixture is aged and then diluted to a silica concentration of not more than 1.0 wt.%. The method achieves reduced silica deposition during the preparation of the microgels.
Patent NZ-510987-A (NZ)
Title: 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
Inventor: HEWAWASAM PIYASENA
IPC: C07D215/227
Filed: 1999-12-01
Abstract: The present invention provides 3-substituted-4-arylquinolin-2-one derivatives having general formula (I) wherein R, R1, R2, R3, R4, R5, R6 and R7 are as defined herein, or a non-toxic pharmaceutically acceptable salt thereof, which are modulators of the large conductance calcium-activated K+ channels and are useful in the treatment of disorders which are responsive to the opening of the potassium channels.
Patent NZ-511309-A (NZ)
Title: Stabilized  setting and hardening accelerator  of  low viscosity
Inventor: BURGE THEODOR A
IPC: C04B22/14
Filed: 2001-04-24
Abstract: A  composition  suitable for  use  as  a  setting  and hardening accelerator comprising at least one aluminum  salt and furthermore: (a)   At  least  one complexing agent for the aluminum  ion; and (b)  At lest one corrosion inhibitor.
Patent NZ-513131-A (NZ)
Title: Antioxidant compositions and methods for companion animals
Inventor: HARPER JEAN E
IPC: A23K1/18
Filed: 2000-01-31
Abstract: A dog or cat foodstuff, diet or supplement which provides a concentration of vitamin E at a level of 25IU/400kcal or above, a concentration of vitamin C of 10mg/400kcal or above and a concentration of taurine of 80mg/400kcal or above. The composition is used for the treatment of any disorder that has a component of oxidative stress, or for strengthening the immune response of a cat or dog, such as when challenged by vaccination.
Patent NZ-516554-A (NZ)
Title: Fat-binding polymers, optionally combined with lipase inhibitors
Inventor: JOZEFIAK THOMAS HENRY
IPC: A61P3/04
Filed: 1999-07-14
Abstract: Use of a polymer, salt or copolymer which is characterized by a combination of repeat units having the formula (IV) where R1, R2 and R3 is H or CH3, R4 is a hydrophobic group, and m is 0-4. Formula (IV) is combined with at least one lipase inhibitor. Use of a polymer, salt or copolymer characterised by a combination of repeat units having the formula (V) where R1 is H or CH3, R4 is a hydrophobic group, R5 is an alkyl chain from C1 to C22, and m is 0-4. Formula (IV) and (V) are used for the treatment of steatorrhea, hypertriglyceridemia and reducing absorption of dietary fat.
Patent NZ-518861-A (NZ)
Title: Treatment of heart rhythm distubances with N6-substituted-5'-(N-substituted) carboxamidoadenosines
Inventor: MARTIN PAULINE L
IPC: C07H19/167
Filed: 2000-11-16
Abstract: Disclosed is the use of compounds of formula (I) in the manufacture of a medicament for treating or preventing heart rhythm disturbances in mammal that would benefit from the induction of negative dromotropic action, negative chronotropic action, or a combination thereof, wherein: R1 is C3-7secondary alkyl, or C3-8cycloakly, and R2 is C1-4alkyl, C1-4hydroxyalkyl or C3-5cycloalkyl. Also disclosed are pharmaceutical compositions in unit dosage forms comprising compounds of formula (I) in amounts effective to treat or prevent heart rhythm disturbances in mammals. Typically the amount is from 1 to 50 ìg/kg of body weight.
Patent NZ-519404-A (NZ)
Title: Enzyme treatment for infection
Inventor: ANDERSON DAVID M
IPC: A23K20/195
Filed: 2000-12-08
Abstract: Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.
Patent NZ-528270-A (NZ)
Title: Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
Inventor: MITSUYA HIROAKI
IPC: A61K45/06
Filed: 2002-03-18
Abstract: A pharmaceutical composition for prevention and/or treatment for HIV infection or AIDS induced by the infection which comprises, as an active ingredient, a triazaspiro[5.5]undecane derivative, a quaternary ammonium salt thereof, an N-oxide thereof, or a non-toxic salt thereof, and if necessary, it may be combined with at least one member of other agents for prevention and/or treatment for HIV infection. The triazaspiro[5.5]undecane derivatives, the quatemary ammonium salts thereof or the N-oxides thereof, or the non-toxic salts thereof are useful in preventing and/or treating HIV infection and AIDS induced by the infection.
Patent NZ-528550-A (NZ)
Title: Aripiprazole oral solution
Inventor: PARAB PRAKASH
IPC: A61P25/18
Filed: 2002-04-24
Abstract: A pharmaceutical solution for oral administration comprises aripiprazole, a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents and one or more agents selected from lactic acid, acetic acid, tartaric acid and citric acid wherein the solution has a pH from 2.5 to 4.5.
Patent NZ-531040-A (NZ)
Title: Strip of fasteners for a fastening apparatus with loading device intended to take the strip, the apparatus and the loading device
Inventor: ALMERAS ROLAND
IPC: F16B15/08
Filed: 2004-02-09
Abstract: Strip of fasteners for a fastening apparatus with a loading device intended to take the strip, each fastener comprising a shank pointed at one end and bearing a head at the other end, the fasteners being engaged respectively via their shanks in guide pegs joined together into a string before they are transferred, one by one, from the loading device to a bore of the apparatus, in a firing position wherein at least one of the guide pegs at the end of the string comprises support means including a lug projecting transversely with respect to the strip, adapted to be received in a groove formed along the loading device and leading to the bore, for preventing tilting of the guide peg as it is transferred from the loading device into the apparatus.
Patent NZ-531919-A (NZ)
Title: Electrocatheter for inducing vessel stenosys having two arrays of diverging electrodes
Inventor: JONES CHRISTOPHER
IPC: A61B18/14
Filed: 1999-08-20
Abstract: A catheter for effecting venal stenosis by thermal effect to structurally transfigure the collagen fibrils of the vein includes a catheter shaft, a movable sheath and a distal working end at which the energy is applied to the walls of the vein. The thermal energy applicator at the working end of the catheter includes two longitudinally spaced apart sets of expandable elements 100, 102 and a single secondary energy application non-expandable tip 106 which is located forward of the expandable elements. In use the catheter is moved through the vein to the site to be transfigured, the sheath is moved back on the shaft to allow the expandable elements to expand into apposition to the wall of the vein, then electrical energy is applied to the elements to heat the elements and the vein wall to make the vein shrink against the bias of the elements to the size of the tip. As the catheter tip is withdrawn from the reduced position it is also heated so that the vein shrinks even further. By having spaced apart heating elements one can accomplish shrinkage over a greater length of the vein.
Patent NZ-536103-A (NZ)
Title: Peptide deformylase inhibitors
Inventor: AUBART KELLY M
IPC: C07D471/04
Filed: 2003-05-30
Abstract: Disclosed is an antibacterial and polypeptide deformylase (PDF) inhibitor of formula (1), in which Y represents O, CH2 or a covalent bond and all other substituents are as provided in the specification.